BACKGROUND: Although long-chain omega-3 fatty acid (n-3 FA) consumption estimated via food-frequency questionnaires has been associated with a higher incidence of diabetes, limited prospective data on diabetes risk are available that use objective biomarkers of n-3 FAs. OBJECTIVE: We sought to examine the relation between plasma phospholipid n-3 FAs and incident diabetes. DESIGN: We prospectively analyzed data in 3088 older men and women (mean age: 75 y) from the Cardiovascular Health Study (1992-2007). Plasma phospholipid n-3 FAs were measured by using gas chromatography, and incident diabetes was ascertained by using information on hypoglycemic agents and serum glucose. We used Cox proportional hazards models to estimate multivariable-adjusted relative risks. RESULTS: During a median follow-up of 10.6 y, 204 new cases of diabetes occurred. In a multivariable model that controlled for age, sex, race, clinic site, body mass index, alcohol intake, smoking, physical activity, LDL cholesterol, and linoleic acid, relative risks (95% CIs) for diabetes were 1.0 (reference), 0.96 (0.65, 1.43), 1.03 (0.69, 1.54), and 0.64 (0.41, 1.01) across consecutive quartiles of phospholipid eicosapentaenoic acid and docosahexaenoic acid (P for trend = 0.05). Corresponding relative risks (95% CIs) for phospholipid α-linolenic acid (ALA) were 1.0 (reference), 0.93 (0.65, 1.34), 0.99 (0.68, 1.44), and 0.57 (0.36, 0.90) (P for trend = 0.03). CONCLUSIONS: With the use of objective biomarkers, long-chain n-3 FAs and ALA were not associated with a higher incidence of diabetes. Individuals with the highest concentrations of both types of FAs had lower risk of diabetes.
BACKGROUND: Although long-chain omega-3 fatty acid (n-3 FA) consumption estimated via food-frequency questionnaires has been associated with a higher incidence of diabetes, limited prospective data on diabetes risk are available that use objective biomarkers of n-3 FAs. OBJECTIVE: We sought to examine the relation between plasma phospholipidn-3 FAs and incident diabetes. DESIGN: We prospectively analyzed data in 3088 older men and women (mean age: 75 y) from the Cardiovascular Health Study (1992-2007). Plasma phospholipidn-3 FAs were measured by using gas chromatography, and incident diabetes was ascertained by using information on hypoglycemic agents and serum glucose. We used Cox proportional hazards models to estimate multivariable-adjusted relative risks. RESULTS: During a median follow-up of 10.6 y, 204 new cases of diabetes occurred. In a multivariable model that controlled for age, sex, race, clinic site, body mass index, alcohol intake, smoking, physical activity, LDL cholesterol, and linoleic acid, relative risks (95% CIs) for diabetes were 1.0 (reference), 0.96 (0.65, 1.43), 1.03 (0.69, 1.54), and 0.64 (0.41, 1.01) across consecutive quartiles of phospholipid eicosapentaenoic acid and docosahexaenoic acid (P for trend = 0.05). Corresponding relative risks (95% CIs) for phospholipid α-linolenic acid (ALA) were 1.0 (reference), 0.93 (0.65, 1.34), 0.99 (0.68, 1.44), and 0.57 (0.36, 0.90) (P for trend = 0.03). CONCLUSIONS: With the use of objective biomarkers, long-chain n-3 FAs and ALA were not associated with a higher incidence of diabetes. Individuals with the highest concentrations of both types of FAs had lower risk of diabetes.
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Dariush Mozaffarian; W T Longstreth; Rozenn N Lemaitre; Teri A Manolio; Lewis H Kuller; Gregory L Burke; David S Siscovick Journal: Arch Intern Med Date: 2005-01-24
Authors: M de Lorgeril; S Renaud; N Mamelle; P Salen; J L Martin; I Monjaud; J Guidollet; P Touboul; J Delaye Journal: Lancet Date: 1994-06-11 Impact factor: 79.321
Authors: William S Harris; James V Pottala; Sean M Lacey; Ramachandran S Vasan; Martin G Larson; Sander J Robins Journal: Atherosclerosis Date: 2012-06-07 Impact factor: 5.162
Authors: Amanda M Fretts; Dariush Mozaffarian; David S Siscovick; Colleen Sitlani; Bruce M Psaty; Eric B Rimm; Xiaoling Song; Barbara McKnight; Donna Spiegelman; Irena B King; Rozenn N Lemaitre Journal: Br J Nutr Date: 2014-08-27 Impact factor: 3.718
Authors: Jason H Y Wu; Renata Micha; Fumiaki Imamura; An Pan; Mary L Biggs; Owais Ajaz; Luc Djousse; Frank B Hu; Dariush Mozaffarian Journal: Br J Nutr Date: 2012-06 Impact factor: 3.718
Authors: Markus J Takkunen; Ursula S Schwab; Vanessa D F de Mello; Johan G Eriksson; Jaana Lindström; Jaakko Tuomilehto; Matti I J Uusitupa Journal: Eur J Nutr Date: 2015-05-01 Impact factor: 5.614
Authors: Ju-Sheng Zheng; Donna K Arnett; Laurence D Parnell; Yu-Chi Lee; Yiyi Ma; Caren E Smith; Kris Richardson; Duo Li; Ingrid B Borecki; Jose M Ordovas; Katherine L Tucker; Chao-Qiang Lai Journal: J Nutr Date: 2013-01-09 Impact factor: 4.798
Authors: Rozenn N Lemaitre; Amanda M Fretts; Colleen M Sitlani; Mary L Biggs; Kenneth Mukamal; Irena B King; Xiaoling Song; Luc Djoussé; David S Siscovick; Barbara McKnight; Nona Sotoodehnia; Jorge R Kizer; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2015-03-18 Impact factor: 7.045
Authors: Luc Djoussé; Andrew B Petrone; Natalie L Weir; Naomi Q Hanson; Robert J Glynn; Michael Y Tsai; J Michael Gaziano Journal: Eur J Nutr Date: 2014-01-07 Impact factor: 5.614